Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration

Fig. 3

Mutational and CNV profiles of co-expressed glycolysis and cholesterogenic genes across bladder cancer metabolic subtypes in the TCGA study. (A) Oncoprint depicting the distribution of SNV/indel and CNV events in the co-expressed glycolytic and cholesterogenic genes across the 4 metabolic subtypes. Fisher exact test was performed to compare the frequencies of alteration across 4 subtypes. *P < 0.05; **P < 0.01; (B) CNV variation frequency of the co-expressed glycolytic and cholesterogenic genes in the TCGA cohort. Column height represents the alteration frequency, the red dot indicates the amplification frequency, and the blue dot indicates the deletion frequency

Back to article page